ThyroSafe is the only FDA approved 65 mg. Potassium Iodide (KI) tablet. It is used to protect your thyroid gland against radioactive iodine released during a nuclear emergency. It does this by flooding the thyroid with stable, safe iodine, which blocks the absorption of dangerous radioactive iodine.
Potassium Iodide (KI) must be taken prior to or soon after exposure of radiation from nuclear fallout in order to be effective, therefore it must be readily on-hand. In the event of a nuclear emergency there simply will not be time to protect your family with potassium iodide if you do not have it already.
Features and Specifications:
Manufacturer Number: NDC-66983-350-20/KI
Information regarding the expiration dates on the K1 Tablets provided by www.nrc.gov
Potassium iodide tablets are inherently stable and do not lose their effectiveness over time. Manufacturers must label their products with a shelf-life to ensure that consumers purchase safe and useful products.
According to FDA guidance on Shelf-life Extension, studies over many years have confirmed that none of the components of KI tablets, including the active ingredient, has any significant potential for chemical degradation or interaction with other components or with components of the container closure system when stored according to labeled directions. To date, the only observed changes during stability (shelf-life) testing have been the failure of some batches of KI tablets to meet dissolution specifications. Some tablets tested required slightly longer than the specified time to achieve dissolution. Even in the case of a failure of this sort, the product remains usable. In such cases, instructions can be provided to crush the tablets and mix the m with a juice or other liquid prior to administration as suggested for emergency pediatric dosing.